MA32635B1 - Produit medicamenteux et traitement associe - Google Patents
Produit medicamenteux et traitement associeInfo
- Publication number
- MA32635B1 MA32635B1 MA33701A MA33701A MA32635B1 MA 32635 B1 MA32635 B1 MA 32635B1 MA 33701 A MA33701 A MA 33701A MA 33701 A MA33701 A MA 33701A MA 32635 B1 MA32635 B1 MA 32635B1
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical product
- associated treatment
- paracetamol
- ibuprofen
- approximately
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
L'invention concerne l'utilisation de paracétamol et d'ibuprofène dans la préparation d'un médicament pour traiter l'ostéoarthrite ou la polyarthrite rhumatoïde. Ce médicament comprend une composition combinée constituée approximativement de 125 à 150 mg d'ibuprofène et approximativement de 475 mg à 500 mg de paracétamol.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ56961208 | 2008-10-14 | ||
| PCT/NZ2009/000220 WO2010044681A1 (fr) | 2008-10-14 | 2009-10-12 | Produit médicamenteux et traitement associé |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA32635B1 true MA32635B1 (fr) | 2011-09-01 |
Family
ID=42106693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA33701A MA32635B1 (fr) | 2008-10-14 | 2011-03-14 | Produit medicamenteux et traitement associe |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20110166234A1 (fr) |
| EP (1) | EP2341900B1 (fr) |
| JP (1) | JP2012505830A (fr) |
| KR (1) | KR20110112279A (fr) |
| CN (1) | CN102215835A (fr) |
| AU (1) | AU2009304002B9 (fr) |
| BR (1) | BRPI0914086A2 (fr) |
| CA (1) | CA2735834C (fr) |
| CH (1) | CH702339B1 (fr) |
| CL (1) | CL2011000678A1 (fr) |
| CO (1) | CO6341553A2 (fr) |
| CY (1) | CY1122198T1 (fr) |
| DK (1) | DK2341900T3 (fr) |
| ES (1) | ES2725151T3 (fr) |
| GB (1) | GB2476418B (fr) |
| HR (1) | HRP20190891T1 (fr) |
| HU (1) | HUE043063T2 (fr) |
| LT (1) | LT2341900T (fr) |
| MA (1) | MA32635B1 (fr) |
| MX (1) | MX340662B (fr) |
| MY (1) | MY153932A (fr) |
| NZ (1) | NZ591496A (fr) |
| PL (1) | PL2341900T3 (fr) |
| PT (1) | PT2341900T (fr) |
| RU (1) | RU2487707C2 (fr) |
| SI (1) | SI2341900T1 (fr) |
| TR (2) | TR201906742T4 (fr) |
| WO (1) | WO2010044681A1 (fr) |
| ZA (1) | ZA201101752B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0512756A (pt) | 2004-07-07 | 2008-04-08 | Aft Pharmaceuticals Ltd | composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas |
| JP2013541583A (ja) * | 2010-11-04 | 2013-11-14 | エイエフティ ファーマスーティカルズ リミテッド | 組み合わせ組成物 |
| WO2016008546A1 (fr) | 2014-07-18 | 2016-01-21 | Everbright Pharmaceuticals S.A.R.L. | Formulation aqueuse comprenant du paracétamol et de l'ibuprofène |
| WO2018192664A1 (fr) | 2017-04-20 | 2018-10-25 | Hyloris Developments Sa | Procédé de préparation d'une composition à faible teneur en oxygène dissous, comprenant de l'acétaminophène, et éventuellement un ou plusieurs ains, et une composition obtenue à partir de celui-ci |
| CN111031996B (zh) * | 2017-07-10 | 2022-04-15 | 盖尔凯普科技有限公司 | 双释放剂型胶囊及其制备方法、装置和系统 |
| US11197830B2 (en) | 2019-02-27 | 2021-12-14 | Aft Pharmaceuticals Limited | Pharmaceutical composition containing acetaminophen and ibuprofen |
| WO2023281089A2 (fr) | 2021-07-08 | 2023-01-12 | Krka, D.D., Novo Mesto | Composition pharmaceutique comprenant du naproxène et du paracétamol |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA837556B (en) * | 1982-11-15 | 1984-06-27 | Upjohn Co | Acetominophen and ibuprofen/flurbiprofen |
| EP0109281A1 (fr) * | 1982-11-15 | 1984-05-23 | The Upjohn Company | Compositions contenant du flurbiprofen ou de l'ibuprofen |
| AU605538B2 (en) * | 1988-01-19 | 1991-01-17 | Adcock Ingram Limited | Pharmaceutical unit |
| CA1336687C (fr) * | 1989-08-23 | 1995-08-15 | Thomas M. Tencza | Mode de preparation de comprimes contenant de l'ibuprofene, de l'acetaminophere et de la cafeine, les produits ainsi obtenue et leurs applications |
| BRPI0512756A (pt) | 2004-07-07 | 2008-04-08 | Aft Pharmaceuticals Ltd | composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas |
| GB0519350D0 (en) * | 2005-09-22 | 2005-11-02 | Boots Healthcare Int Ltd | Therapeutic agents |
| US20090264530A1 (en) * | 2008-04-16 | 2009-10-22 | Nickell Robert P | Combined nsaid and acetaminophen formulation and method |
-
2009
- 2009-10-12 HR HRP20190891TT patent/HRP20190891T1/hr unknown
- 2009-10-12 TR TR2019/06742T patent/TR201906742T4/tr unknown
- 2009-10-12 JP JP2011530978A patent/JP2012505830A/ja active Pending
- 2009-10-12 MY MYPI2011001017A patent/MY153932A/en unknown
- 2009-10-12 KR KR1020117011015A patent/KR20110112279A/ko not_active Ceased
- 2009-10-12 TR TR2011/02810T patent/TR201102810T2/xx unknown
- 2009-10-12 CN CN2009801365433A patent/CN102215835A/zh active Pending
- 2009-10-12 EP EP09820803.6A patent/EP2341900B1/fr active Active
- 2009-10-12 LT LTEP09820803.6T patent/LT2341900T/lt unknown
- 2009-10-12 ES ES09820803T patent/ES2725151T3/es active Active
- 2009-10-12 PL PL09820803T patent/PL2341900T3/pl unknown
- 2009-10-12 DK DK09820803.6T patent/DK2341900T3/da active
- 2009-10-12 GB GB1105249.5A patent/GB2476418B/en not_active Expired - Fee Related
- 2009-10-12 MX MX2011003928A patent/MX340662B/es active IP Right Grant
- 2009-10-12 RU RU2011111792/15A patent/RU2487707C2/ru active IP Right Revival
- 2009-10-12 BR BRPI0914086A patent/BRPI0914086A2/pt not_active Application Discontinuation
- 2009-10-12 HU HUE09820803A patent/HUE043063T2/hu unknown
- 2009-10-12 CH CH00658/11A patent/CH702339B1/de not_active IP Right Cessation
- 2009-10-12 PT PT09820803T patent/PT2341900T/pt unknown
- 2009-10-12 AU AU2009304002A patent/AU2009304002B9/en not_active Ceased
- 2009-10-12 SI SI200931962T patent/SI2341900T1/sl unknown
- 2009-10-12 WO PCT/NZ2009/000220 patent/WO2010044681A1/fr not_active Ceased
- 2009-10-12 CA CA2735834A patent/CA2735834C/fr active Active
- 2009-10-12 US US13/062,985 patent/US20110166234A1/en not_active Abandoned
- 2009-10-12 NZ NZ591496A patent/NZ591496A/xx unknown
-
2011
- 2011-03-07 ZA ZA2011/01752A patent/ZA201101752B/en unknown
- 2011-03-14 MA MA33701A patent/MA32635B1/fr unknown
- 2011-03-28 CL CL2011000678A patent/CL2011000678A1/es unknown
- 2011-05-13 CO CO11058771A patent/CO6341553A2/es not_active Application Discontinuation
-
2019
- 2019-04-05 CY CY20191100377T patent/CY1122198T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA32635B1 (fr) | Produit medicamenteux et traitement associe | |
| MA34517B1 (fr) | Promédicaments comprenant un conjugué exendine-lieur | |
| CY1119140T1 (el) | Συνθεσεις αντικωδικευσης και μεθοδοι κατασκευης και χρησης τους | |
| EP1848270A4 (fr) | Administration par voie transmuqueuse de compositions medicamenteuses pour le traitement et la prevention de troubles chez les animaux | |
| EP2331095A4 (fr) | Certains inhibiteurs de kynurénine-3-monooxygénase, compositions pharmaceutiques, et procédés d'utilisation de ceux-ci | |
| MA34296B1 (fr) | Composition retard injectable antipsychotique | |
| ITRM20070429A1 (it) | Mezzi per la diagnosi la prevenzione e la cura dell'artrite reumatoide. | |
| EP1988910A4 (fr) | Conjugués de polymères contenant de l'acryloyloxyéthylphosphorylcholine et leur préparation | |
| FR2908999B1 (fr) | Nouveau medicament destine a l'inhibition, la prevention ou le traitement de la polyarthrite rhumatoide. | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| MY172157A (en) | Thioninium compounds and their use | |
| BR112014004741A2 (pt) | pelo menos uma entidade química; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada | |
| NZ595127A (en) | Stable pharmaceutical composition for atherosclerosis | |
| BR112013010829B8 (pt) | Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação | |
| EA201270071A1 (ru) | Способ лечения пациента, нуждающегося в аспириновой терапии | |
| MA29722B1 (fr) | Schema posologique pour le prasugrel | |
| GB0700027D0 (en) | A combination composition | |
| MA33602B1 (fr) | Composition pharmaceutique permettant de prévenir ou de traiter l'arthrite rhumatoïde, contenant du rébamipide | |
| MY149863A (en) | Delayed-release glucocorticoid treatment of rheumatoid disease | |
| JP2012505830A5 (fr) | ||
| TW200806293A (en) | Methods of treatment with CETP inhibitors | |
| CA2632207C (fr) | Utilisation de calcitonine pour traiter la pr | |
| EP2307006A4 (fr) | Composition pharmaceutique contenant un dérivé de 1,2-dithiolthione pour la prévention ou le traitement d une maladie causée par la surexpression de lxr-alpha | |
| MA39448A1 (fr) | (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical | |
| DE602006021348D1 (de) | Feste form von amg 706 und pharmazeutische zusammensetzungen davon |